Building More Resilience in America

Learn about Fresenius Kabi’s plan to more than double our U.S. manufacturing capacity in the next 5 years. [Read More]

At Fresenius Kabi, we’re doing More in America.

Our purpose is caring for life – putting lifesaving medicines and technologies in the hands of people who care for patients and finding solutions to their challenges. Our focus is delivering the support caregivers need every day, and just as important, preparing for what they may need next. Our history in health care goes back more than 100 years. We work shoulder-to-shoulder with health care professionals to help improve medication safety, design products that are easy to use, and help make medicines more accessible and affordable across the continuum of care in America.

Resilience is critical in health care. Hear how Fresenius Kabi is doing more in America to build resilience into the supply chain of care.
[Learn more]

More in America Infographic

We are making significant progress in bringing more products, more choice and more innovation to our customers in the U.S. Check out our infographic for a quick overview. [View PDF]

Our commitment to more supply, science and support in America is a reason our customers can deliver patient care with more confidence.

Since 2017, Fresenius Kabi has invested nearly $1 billion to expand and modernize advanced U.S. pharmaceutical production and distribution facilities. More than 70% of the units shipped by Fresenius Kabi in the U.S. are drugs listed on the FDA’s Essential Medicines List.¹

From vials to ready-to-administer premixed medicines and convenient prefilled syringes, Fresenius Kabi is continuously enhancing its processes, products and packaging to optimize the availability and safe delivery of medicines throughout hospitals and clinics.

Putting confidence within reach. Our people, products and processes are all focused on supporting our customers in America and helping to bring more confidence to clinicians and their patients.

Our purpose is caring for life and our 40,000 team members worldwide are dedicated to working together to help find solutions for caregivers and their patients.

What this all means for our U.S. customers is a more reliable supply of the medications patients need and less vulnerability when there are increased supply demands and other disruptions. We invite you to explore more about how Fresenius Kabi is doing More in America to serve you better.

1. 2023 Data on file; https://www.fda.gov/media/143406/download

Click here to read more about how Fresenius Kabi is doing More in America.